The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
03/16/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
The purpose of this modification is to correct/clarify the Application Instructions with regard to research involving animal use. Research involving animal is acceptable under this Program Announcement. The Application Instructions at Appendix 5, Section C are changed to read as follows:
“Specific documents relating to the use of animals in the proposed research will be requested if the Application is selected for funding (these documents should not be submitted with the Application). The ACURO, a component of the USAMRMC ORP, must review and approve all animal use prior to the start of working with animals. PIs must submit the institutional animal use protocol, IACUC approval of that protocol, and a version the animal use appendix entitled “Research Involving Animals.” For guidance on which version of the appendix to use as well as links to both, visit the ACURO website at: https://mrmc.amedd.army.mil/index.cfm?pageid= Research _Protections.acuro _Animalappendix. Allow 2 to 4 months for regulatory review and approval processes for animal studies. For additional information, send an email with questions to ACURO (ACURO@amedd.army.mil).”
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-11-MRPRA-TRA
Opportunity Category:
Discretionary
Posted Date:
Mar 16, 2012
Creation Date:
Apr 06, 2012
Original Closing Date for Applications:
Apr 16, 2012
Current Closing Date for Applications:
Apr 16, 2012
Archive Date:
May 16, 2012
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
8
Estimated Total Program Funding:
$4,000,000
Award Ceiling:
$500,000
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The Assistant Secretary of Defense for Health Affairs, Defense Health Program Medical Research and Development Office is soliciting proposals for the FY11 Militarily Relevant Peer Reviewed Alzheimer’s Disease Research Program (MRPRA) to be awarded during Calendar Year 2012. The Telemedicine and Advanced Technology Research Center (TATRC) is administering the application process for this funding opportunity, and the United States Army Medical Research Acquisition Activity (USAMRAA) is issuing this Program Announcement and will be negotiating all resulting awards.The mission of the MRPRA is to build an integrated program devoted towards understanding the association between Traumatic Brain Injury (TBI) and Alzheimer’s Disease (AD) and reducing the burden on those affected. Military personnel who suffer severe or moderate TBI face an increased risk for developing several long-term health problems. These conditions include Alzheimer's-like dementia, aggression, memory loss, depression, and symptoms similar to those of other neurological diseases. Even mild TBI may be associated with some of these adverse consequences. Therefore, the primary objective of the FY11 MRPRA is to facilitate the development of research tools and clinical outcomes that will permit the detection and diagnosis of neurological change found with TBI-associated AD. A second but equally important objective for the FY 11 MRPRA is the development of technologies intended to directly benefit individuals suffering from the symptoms of neurological impairment associated with either TBI or AD. Research falling under this second objective is intended to either increase or maintain the quality of life of those affected by either TBI or AD.The results of the research funded through this Program Announcement/Funding Opportunity are expected to generate research resources for professionals and practitioners in health, medical science and related fields related to the MRPRA’s mission. The research impact is expected to benefit the military community, while meeting a public purpose for the benefit of the civilian community.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
